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Background
Over 1 million pacemakers and over 320,000 implantable cardioverter-defibrillators 
(ICDs) were implanted worldwide in 2009, and the implantation of cardiovascular 
implantable electronic devices (CIEDs) is on the rise [1–3]. Placing a magnet on a car-
diac pacemaker usually enables an asynchronous mode in which the heart is paced at 
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Methods: Thirty patients were recruited to compare a new prototype surgical mag‑
netic drape (LT10G™ by Menodys) made with bottom‑isolated ferrite magnets to the 
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magnetic drapes.
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patients (25 %) displayed magnetic interference with a second type of surgical mag‑
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Conclusion: Bottom isolation of magnets in the prototype magnetic drape (LT10G™) 
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a predetermined frequency [4–7]. However, this magnet-activated asynchronous mode 
may have undesirable consequences, such as battery depletion, undesirable hemo-
dynamic effects due to rapid pacing in some pacemakers, and rarely, ventricular dys-
rhythmias if pacemaker stimulation occurs in the vulnerable part of the cardiac cycle in 
patients with an intrinsic cardiac rhythm [4, 8–12]. In patients with an ICD, application 
of a magnet does not enable asynchronous pacing, but rather may suppress the detec-
tion of arrhythmias and prevents the device from delivering the appropriate therapy 
[4–6, 11, 12].
Sterile magnetic drapes are commonly used during surgery to hold metal instruments 
in the sterile field. The drape is often placed on the patient’s thorax, the usual location 
for a CIED. The placement of a magnetic drape over a pacemaker has been reported to 
result in unintended tachycardia and cardiac arrest [13]. In a previous study [14], it was 
found that surgical magnetic drapes are likely to activate the magnetic switch and cause 
asynchronous pacing in most patients when placed over the pacemaker. The magnetic 
drape tested in that study contained 70 ceramic ferrite magnets (116 Reusable Drape 
#31140588, Devon by Covidien, Mansfield, MA, USA). According to manufacturer’s 
specifications, over 5–10 Gauss is required to enable the asynchronous mode in the 
pacemakers tested in that study [14], a level reached when one of the 70 ferrite magnets 
from the drape is 3.4 cm away from the generator. There are several ways to reduce the 
magnetism of the drape, including alternating the polarities of adjacent magnets, or add-
ing an isolating material between the magnet and the pacemaker.
Therefore, the purpose of this study was twofold. First, to compare the interference 
generated by the magnetic drape from Covidien used in a previous study [14] with a 
prototype magnetic drape manufactured with bottom-isolated ferrite magnets, cur-
rently commercialized as the LT10G™ by Menodys since September 2014, in order to 
determine in patients with a cardiac pacemaker whether asynchronous mode behavior 
develops. The second part of our study compares four different commercially available 
surgical magnetic drapes with the prototype drape containing bottom-isolated ferrite 
magnets. Our hypothesis is that placement of commercially available surgical magnetic 
drapes may result in asynchronous pacing in pacemaker patients, whereas the prototype 
magnetic drape with bottom-isolated ferrite magnets will not cause asynchronous pac-
ing in these same patients.
Methods
Following approval of the research ethics committee of the Maisonneuve-Rosemont 
Hospital affiliated to the University of Montreal, patients with an implanted cardiac 
pacemaker (Medtronic, Minneapolis, Minnesota, and Boston Scientific, Natick, MA, 
USA) were recruited for this study from October 2011 until November 2011 during 
regular device follow-up visits at the outpatient pacemaker clinic. After the cardiologist 
performed the initial scheduled device interrogation, the protocol was explained to all 
patients, and those who agreed to participate in the study, signed a written consent form.
Patient data including age, sex, height, weight, body mass index (BMI) were recorded. 
The protocol was performed with the patient supine, wearing a hospital gown. Continu-
ous 3-lead electrocardiographic (ECG) monitoring was placed on the patient and the 
ECG was analysed by a medical Doctor (MD), an anesthesiologist or an anesthesiology 
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senior resident, as well as a registered Nurse (RN) throughout the study. First, a strip of 
the patient’s baseline rhythm was obtained. Then, a Medtronic round magnet (#174105-
2, Minneapolis, MN, USA) was placed on the pacemaker and a copy of the ECG to con-
firm the magnet mode behavior as specified by the manufacturer was obtained. Patients 
with ICDs and patients in whom the magnet rate cardiac rhythm was indistinguishable 
from their baseline rhythm were excluded. The round magnet was then removed.
Part 1 of the study was to assess two different magnetic drapes. A member of the per-
sonnel not involved in the study concealed the two magnetic drapes in an opaque plastic 
bag. The first drape (“CVD”) measured 29.5  cm ×  37.5  cm and contained 70 ceramic 
ferrite magnets (116 Reusable Drape #31140588, Devon by Covidien, Mansfield, MA, 
USA) (Fig. 1). In a previous study [14], the magnets in the CVD drape were found to 
be inserted in a random fashion, regardless of polarity. In a single drape, the polarity 
of each magnet can impact the overall vector of magnetism of that drape. Thus, at the 
beginning of each data collection day, a different CVD drape was used in order to reduce 
bias caused by the potential magnetic signature of each commercial drape. The second 
magnetic drape was a prototype made with a silicone shell similar to the CVD drape, but 
instead contained 70 isolated ferrite magnets (Fig. 2). The isolation material consisted of 
a steel-based metal cup that diminished the magnetic remanence on the patient side of 
the drape and only encapsulated the underside of each ferrite magnet in order to create 
a unidirectional magnetic field. The overall magnetic field on the patient facing side was 
less than 10 Gauss (Fig. 3) (Additional file 1).
Each magnetic drape was concealed and centered over the patient’s pacemaker, with 
the help of a measuring tape, one after the other. The investigator performing the study 
and the data collector were both blinded to the type of magnetic drape. Magnetic inter-
ference was identified if the cardiac rhythm was asynchronous and identical to that pro-
duced by the round magnet rhythm. If there was no change in rhythm with the magnetic 
drape, the drape was displaced in 1–2 cm increments over the pacemaker in an effort 
Fig. 1 CVD surgical magnetic drape containing 70 ceramic ferrite magnets
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to elicit an asynchronous rhythm. Once the protocol was completed, the patient was 
referred to the cardiologist who, if the situation permitted, discharged the patient.
Part 2 of the study consisted of evaluating and comparing 4 different commercially 
available magnetic drapes, including the CVD, with the prototype magnetic drape. All 
four of these commercially available magnetic drapes underwent the same protocol as 
the magnetic drapes in part 1 of the study. Due to the different sizes and shapes of the 
four drapes, it was not possible to create a blinded evaluation with an opaque plastic 
bag. The magnetic drapes evaluated were the CVD magnetic drape, the “JCM” magnetic 
drape (Reusable Magnetic Pad, Jac-Cell Medic, Town of Mount-Royal, Quebec, Canada), 
the “LDR” magnetic drape (Magnetic Instrument Pad #25-002, size 20″ × 16″, DeRoyal 
Industries Inc., Powell, TN, USA), and the “SDR” magnetic drape (Magnetic Instrument 
Pad #25-001, size 10″ × 16″, DeRoyal Industries Inc., Powell, TN, USA).
The sample size calculation for the primary outcome (first part of the study) was based 
on the direct comparison between the proportion of patients experiencing pacemaker 
interference associated with the CVD drape in one group and the new prototype in 
the other. A previous study having shown that using the CVD drape caused pacemaker 
interference in 70 % of participants [14], we elected to look for a 50 % reduction (from 70 
to 35 %) in interference with the prototype drape. It was then calculated that 30 patients 
per group were needed to show such a difference with alpha and beta errors of 0.05 and 
0.8 respectively.
The sample size calculation for part 2 was to be derived from the results obtained dur-
ing the first part of the study, using the proportion of patients experiencing interference 
with the prototype as a base for calculation. Since no case of interference was observed, it 
was arbitrarily decided to recruit twenty participants to provide an exploratory overview 
of the pacemaker interference associated with the various commercially available devices.
Fisher’s exact test was used for comparisons in the first part of the study. Only descrip-
tive statistics were used for the second part. Calculations and analyses were performed 
with Prism 5.0 statistical package (GraphPad Software Inc, La Jolla, CA, USA). Unless 
Fig. 2 Prototype surgical magnetic drape with a silicone shell similar to the CVD drape, but instead contains 
70 bottom‑isolated ceramic ferrite magnets
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stated otherwise, data are presented as mean ±  SD and a p value  <0.05 was deemed 
significant.
Results
Demographic criteria of the patients for both parts of the study are listed in Table  1. 
Thirty patients were recruited in part 1, and three were excluded due to a clerical mis-
take in the make and model of magnetic drape that had been placed in the opaque plas-
tic bag. Of the 27 patients studied, 17 had a Boston Scientific pacemaker and 10 patients 
had a Medtronic pacemaker. All pacemakers were placed subcutaneously. Seventeen 
patients (63 %) displayed asynchronous cardiac pacing when the CVD drape was placed 
over the pacemaker, whereas none of the patients displayed magnetic interference with 
the prototype drape (p < 0.0001) (Table 2).
Fig. 3 Magnetic field of the prototype drape on the patient facing side demonstrating an overall magnetic 
remanence less than 10 Gauss as measured at a distance of 0.165″ from the drape
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In part 2 of the study, 20 patients were recruited and studied. Nine had a Boston Scien-
tific pacemaker and 11 patients had a Medtronic pacemaker. All pacemakers were placed 
subcutaneously. Sixteen patients (80 %) demonstrated asynchronous cardiac pacing with 
the CVD drape. For the JCM magnetic drape, 5 patients (25 %) displayed asynchronous 
cardiac pacing. The LDR magnetic drape did not cause asynchronous cardiac pacing in 
any patient. The unfolded SDR drape displayed asynchronous cardiac pacing in 1 patient 
(5 %). No patients demonstrated asynchronous cardiac pacing with the prototype drape. 
No patients exhibited any adverse outcomes during the study (Table 3). Detailed results 
for each patient are available in Appendix.
Discussion
The findings in this study suggest that bottom-isolation of the magnets in an unfolded 
magnetic drape used during surgery prevents asynchronous pacing in all patients when 
placed over the pacemaker. Three of the four commercially available magnetic drapes 
tested demonstrated asynchronous cardiac pacing.
For both parts of this study, the CVD drape caused asynchronous pacing in a total 
of 33 patients (70 %). These results mirror a previous study [14] where 70 % of patients 
demonstrated asynchronous rhythm with the CVD magnetic drape. Although the JCM 
magnetic drape caused asynchronous pacing in 25 % of patients, this is less than that of 
the CVD magnetic drape. This is possibly due to the fact that the magnets of the JCM 
drape are placed further apart creating a weaker magnetic field compared to those in the 
CVD. Since we did not test the remanence of the individual magnets in each of the com-
mercially available magnetic drapes in this study, we cannot postulate on the strength of 
their remanence compared to the magnets in the CVD.
Among the other commercially available drapes, the LDR magnetic drape did not 
exhibit magnetic pacemaker interference. Considering the LDR magnetic drape is of the 
same make and model as the SDR drape, but simply 10″ larger, it is possible that our 
sample size of 20 patients was not adequate to elicit asynchronous rhythm with the LDR 
drape. In a previous study [14], it was suggested that a single well-positioned magnet 
can induce asynchronous rhythm. Thus, it is possible that the position of the magnets 
in the SDR drape we tested created a stronger magnetic field than those of that particu-
lar LDR drape. This may no longer be true when switching for another identical LDR 
or SDR drape of the same make and model. Unfortunately, we did not test for this in 
our study. Contrary to the CVD and JCM drapes, the LDR and SDR drapes are dispos-
able, and it is possible that the remanence of the disposable drapes may be lesser or may 
Table 1 Demographic data
SD standard deviation
Demographic Part 1 Part 2
Patients N = 27 N = 20
Gender M 15:F 12 M 10:F 10
Age (years) (mean ± SD) 79 ± 8 78 ± 8
Height (m) (mean ± SD) 1.67 ± 0.07 1.66 ± 0.09
Weight (kg) (mean ± SD) 75 ± 17.6 73 ± 16
Body mass index (kg/m2) (mean ± SD) 27 ± 5.2 27 ± 4
Type of pacemaker (Boston Scientific/Medtronic) 17/10 9/11
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have diminished during the study period, as they are meant for single use only. From our 
results, it is reasonable to propose that at least a subset of the magnetic drapes produced 
by this company may generate magnetic interference with pacemakers.
The prototype magnetic drape, currently commercialized as the LT10G™ by Menodys, 
is manufactured to diminish the magnetic remanence on the patient facing side of the 
drape. This is achieved by having each individual magnet of the drape encapsulated in a 
cup with a steel-based metal isolation material. Due to this technology, no patient in our 
study demonstrated an asynchronous cardiac rhythm with the LT10G™ magnetic drape.
Limitations
Our study was limited to the magnetic drapes and pacemakers tested. Thus, our results 
may not apply to all commercially available magnetic drapes and pacemakers. In addi-
tion, our sample size for the second part of our study was arbitrarily determined and 
may warrant further investigation with more patients and different types of magnetic 
drapes and pacemakers.
Few studies have described the risk of interference between magnets and CIEDs, and 
only one study has specifically examined magnetic surgical drapes and it demonstrated 
that the unfolded CVD magnetic drape caused asynchronous rhythm in 70 % of patients 
[14]. In addition, the authors describe that magnetic interference decreases markedly 
with increasing caudal distance from the pacemaker. Other studies describe the risk of 
interference between magnets and CIEDs. Ryf et  al. [15]. demonstrated in an in  vitro 
study that different neodymium magnets found in everyday life, such as in toys and jew-
elry can all activate asynchronous pacing modes in pacemakers when placed at various 
distances from the device. Magnetic interference with different neodymium magnets 
Table 2 Results from Part 1 of the study (n = 27)
Asynchronous rhythm
CVD drape Prototype drape
Patients (%) N = 17 (63 %) N = 0
Age (years) (mean ± SD) 81 ± 6 N/A
Gender M 11/F 6 N/A
Weight (kg) (mean ± SD) 74 ± 18 N/A
Height (m) (mean ± SD) 1.68 ± 0.07 N/A
Body mass index (kg/m2) (mean ± SD) 26 ± 5 N/A
Pacemaker (Boston Scientific/Medtronic) 7/10 N/A
Table 3 Results from part 2 of the study (n = 20)
Drapes tested Prototype CVD JCM SDR LDR
Patients who demonstrated asynchronous 
rhythm (%)
N = 0 N = 16 (80 %) N = 5 (25 %) N = 1 (5 %) N = 0
Age (years) (mean ± SD) N/A 80 ± 7 82 ± 7 87 N/A
Gender N/A M 7/F 9 M 4/F 1 M 0/F 1 N/A
Weight (kg) (mean ± SD) N/A 69 ± 15 70 ± 18 44 N/A
Height (m) (mean ± SD) N/A 1.66 ± 0.09 1.74 ± 0.08 1.52 N/A
Body mass index (kg/m2) (mean ± SD) N/A 26 ± 4 26 ± 3 19 N/A
Pacemaker (Boston Scientific/Medtronic) N/A 6/10 3/2 0/1 N/A
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occurred when placed up to 3 cm to the device [16]. Prolonged exposure to similar mag-
nets were implicated in intermittent, erratic behavior of an ICD [17] and deactivation of 
an ICD resulting in a fatal consequence [18]. In a clinical study by Hiller et al. [19], three 
of 12 patients with a pacemaker experienced interference by small dental mini-magnets. 
The effect disappeared once the magnets were pulled 1 cm away.
Conclusion
Commercially available surgical magnetic drapes may result in asynchronous pacing. 
Three of the four commercially available magnetic drapes tested demonstrated magnetic 
interference. The prototype magnetic drape with bottom-isolated ferrite magnets tested 
in our study did not cause asynchronous pacing in these same patients. This new tech-
nology has the potential to enhance the safety of the operating room environment for 
patients with CIEDs. Flipping the prototype drape is not recommended as it may expose 
non-isolated magnets to the CIED.
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